August 2, 2015
Recommended Topic Related To:

Elspar

"The U.S. Food and Drug Administration today approved Akynzeo (netupitant and palonosetron) to treat nausea and vomiting in patients undergoing cancer chemotherapy.

Akynzeo is a fixed combination capsule comprised of two drugs. Oral palonose"...

Elspar




PATIENT INFORMATION

Advise patients to contact health care professional immediately to report any of the following:

  • swelling of the face, arms or legs, with or without pain in the arm or leg
  • acute difficulty in breathing/shortness of breath
  • severe headache, seizures, change in mental status
  • new onset chest pain
  • severe abdominal pain

Advise patients to inform their healthcare professional of:

  • excessive thirst or an increase in the volume or frequency of urination
  • pregnancy

Last reviewed on RxList: 7/26/2013
This monograph has been modified to include the generic and brand name in many instances.

Report Problems to the Food and Drug Administration

 

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


Cancer

Get the latest treatment options.